View Featured Offers >>

CST Chief Scientific Officer Roberto Polakiewicz Receives CiteAb Significant Individual Impact Award for Contributions to Scientific Rigor in Antibody Development

Company also recognized for its innovative spatial biology tool SignalStar™ Multiplex Immunohistochemistry (mIHC) and as the Antibody Supplier Succeeding in South Korea

Danvers, MA, USA, March 26, 2024Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced that it was recognized in three categories in the 2024 CiteAb Awards, which highlight the best suppliers and individuals in the research reagent sector worldwide.

CST was recognized in the following categories:

  • Award for Significant Individual Impact: Roberto (Roby) Polakiewicz, PhD, Chief Scientific Officer at CST, was recognized for his commitment to high-quality antibody manufacturing, including the development of novel antibody methods and steadfast advocacy for scientific reproducibility standards for antibody manufacturers.
  • Antibody Supplier Succeeding in South Korea: Based on an analysis of CiteAb’s antibody reagent citation database, CST was the company with the most citations for antibodies in South Korea over the past year.
  • Innovation Award: The SignalStar™ Multiplex Immunohistochemistry (mIHC) assay was Highly Commended in CiteAb’s Innovation Award category. The solution is a flexible, out-of-the-box tool for spatial biology research that uses mid-plex, high-throughput IHC assays for up to 8-plex amplification in two days.

“[Roby] has ensured scientific rigor and reproducibility are at the heart of Cell Signaling Technology's antibody generation and validation processes, something which led to the company's reputation for producing high-quality antibodies,” said Andrew Chalmers, CiteAb CEO. “I think thousands of researchers will unknowingly owe him a debt of gratitude for their successful experiments and I'm sure many will join me in congratulating Roby!”

SignalStar Multiplex IHC

“Without experimental reproducibility, scientific integrity is lost, and researchers cannot be confident in their findings,” says Roby Polakiewicz. “A highlight of my career since the founding of CST nearly 25 years ago has been establishing and scaling our culture of scientific rigor, which has led to our stringent antibody validation processes. As a result, I have found myself advocating for reproducibility standards for the antibody industry as a whole. It is an honor to be recognized by CiteAb for the role our work has played in moving the industry forward and enabling more responsible, reproducible science.”

As a global supplier of high-quality antibodies that are used by research teams worldwide, CST is proud to be recognized as the antibody supplier with the most citations in South Korea, a growing epicenter for scientific discovery.

"We have recently noticed that South Korea has been seeing an uptick in the number of citations it's outputting,” said Rhys Williams, Head of Antibody Data at CiteAb. “We want to extend our congratulations to Cell Signaling Technology for their win in this category, which showcases their support of researchers in this growing research hotspot by providing antibodies that are being used frequently in published work.”

The SignalStar mIHC assay was also recognized as highly commended in CiteAb’s Innovation Award category. The solution is a transformative new technology for spatial biology research that uses a proprietary technology to amplify antibody signals, allowing for the detection of targets with low expression levels. A key innovation is the technology’s flexibility in antibody panel design—the SignalStar antibodies and fluorophores are interchangeable, so as research evolves and new targets are identified, researchers can switch out targets and quickly redesign panels without the need for additional panel or protocol optimization. This unparalleled flexibility delivers results up to 70% faster than some other mIHC methods.

CST has a long history of strong performance in awards and recognition by CiteAb, including being named the Post Translational Modification (PTM) Antibody Supplier of the Year in 2023 and the Antibody Supplier of the Decade in 2020. Recently, CST received the 2023 Innovation Award for anti-CAR linker antibodies and was recognized as the Supplier Succeeding in Cancer Research.

Learn more about CiteAb and the 2024 Awards by visiting:

About CiteAb

CiteAb provides world-class data that accelerates scientific research. The company’s industry-leading data collection technology combines machine learning and extensive human reviewing to identify and understand reagent use from scientific publications. This highly accurate data is used to power all of their products, which help researchers find and suppliers sell the best reagents. CiteAb’s search engine ranks products by citations, fundamentally changing the way researchers find products for their experiments, and the company’s data-based products are used to inform suppliers globally. Over 4 million pages of information were served to CiteAb users in the last year, from searches of over 6.8 million reagents. CiteAb is a committed group of biologists and computer scientists dedicated to helping the world's best scientists and suppliers tackle the big problems in life science research. For more information, visit

About Cell Signaling Technology

Cell Signaling Technology (CST) is a different kind of life science company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor. Founded in 1999 and headquartered in Danvers, Massachusetts, USA, CST employs over 600 people worldwide. We consistently provide fellow scientists around the globe with best-in-class products and services to fuel their quests for discovery. CST is a company of caring people driven by a devotion to facilitating good science—a company committed to doing the right thing for our Customers, our communities, and our planet.

CST Media and Press

Rebecca J. Reppucci, MBA
Cell Signaling Technology, Inc.
Senior Director, Global MarComm & Technology
Phone: 978-880-3334
email: [email protected]